SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 121 filers reported holding SUTRO BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 2.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $40,842 | -25.1% | 11,770 | +0.3% | 0.00% | – |
| Q2 2023 | $54,555 | +14.3% | 11,732 | +13.6% | 0.00% | – |
| Q1 2023 | $47,725 | -49.5% | 10,330 | -11.6% | 0.00% | – |
| Q4 2022 | $94,455 | -10.0% | 11,690 | -9.6% | 0.00% | – |
| Q1 2022 | $105,000 | -55.9% | 12,929 | -19.1% | 0.00% | – |
| Q4 2021 | $238,000 | -18.2% | 15,990 | +3.7% | 0.00% | -100.0% |
| Q3 2021 | $291,000 | -19.8% | 15,414 | -21.0% | 0.00% | 0.0% |
| Q2 2021 | $363,000 | +7.1% | 19,522 | +30.9% | 0.00% | 0.0% |
| Q1 2021 | $339,000 | +28.9% | 14,911 | +22.9% | 0.00% | 0.0% |
| Q4 2020 | $263,000 | – | 12,137 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $33,918,000 | 14.78% |
| Samsara BioCapital, LLC | 1,675,579 | $31,149,000 | 3.84% |
| First Light Asset Management, LLC | 2,072,875 | $38,535,000 | 2.31% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,253,000 | 1.88% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $18,616,000 | 1.72% |
| Opaleye Management Inc. | 496,900 | $9,237,000 | 1.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,590,000 | 0.68% |
| Parkman Healthcare Partners LLC | 163,389 | $3,037,000 | 0.66% |
| Eventide Asset Management | 2,370,975 | $44,076,000 | 0.59% |
| BVF INC/IL | 826,825 | $15,371,000 | 0.58% |